My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 133

    1.

    Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

    Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut JG, Arnoux D, Charpiot P, Freyssinet JM, Oliver C, Sampol J, Dignat-George F.

    Diabetes. 2002 Sep;51(9):2840-5.PMID: 12196479 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes.

    Nomura S, Shouzu A, Omoto S, Nishikawa M, Iwasaka T, Fukuhara S.

    Clin Appl Thromb Hemost. 2004 Jul;10(3):205-15.PMID: 15247977 [PubMed - indexed for MEDLINE]Related articles

    3.

    Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.

    Omoto S, Nomura S, Shouzu A, Nishikawa M, Fukuhara S, Iwasaka T.

    Diabetologia. 2002 Apr;45(4):550-5.PMID: 12032632 [PubMed - indexed for MEDLINE]Related articles

    4.

    Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.

    Koga H, Sugiyama S, Kugiyama K, Fukushima H, Watanabe K, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.

    Eur Heart J. 2006 Apr;27(7):817-23. Epub 2006 Jan 24.PMID: 16434416 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus.

    Morel O, Hugel B, Jesel L, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Freyssinet JM, Toti F.

    Thromb Haemost. 2004 Feb;91(2):345-53.PMID: 14961163 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Sodium-proton exchanges and platelet procoagulant activity in type 1 diabetic patients]

    Telejko B, Tomasiak M, Stelmach H, Kinalska I.

    Pol Arch Med Wewn. 2002 Jun;107(6):533-7. Polish. PMID: 12371386 [PubMed - indexed for MEDLINE]Related articles

    7.

    Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.

    Osar Z, Samanci T, Demirel GY, Damci T, Ilkova H.

    Exp Diabesity Res. 2004 Apr-Jun;5(2):155-62.PMID: 15203886 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction.

    Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, D'Ercole C, Dignat-George F.

    Thromb Haemost. 2003 Mar;89(3):486-92.PMID: 12624632 [PubMed - indexed for MEDLINE]Related articles

    9.

    Endothelial microparticles correlate with erectile dysfunction in diabetic men.

    Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR, Beneduce F, Rispoli M, De Sio M, Giugliano D.

    Int J Impot Res. 2007 Mar-Apr;19(2):161-6. Epub 2006 Aug 10.PMID: 16900206 [PubMed - indexed for MEDLINE]Related articles

    10.

    Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

    Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, Sakamoto T, Yoshimura M, Jinnouchi H, Ogawa H.

    J Am Coll Cardiol. 2005 May 17;45(10):1622-30.PMID: 15893178 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus.

    Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK.

    Circulation. 2002 Nov 5;106(19):2442-7.PMID: 12417540 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Factors influencing platelet procoagulant activity in type II diabetic patients. The role of sodium-proton exchange]

    Telejko B, Kinalska I, Stelmach H, Tomasiak M.

    Przegl Lek. 2003;60(9):553-6. Polish. PMID: 15065331 [PubMed - indexed for MEDLINE]Related articles

    13.

    Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy.

    van der Planken MG, Vertessen FJ, Vertommen J, Engelen W, Berneman ZN, De Leeuw I.

    Clin Appl Thromb Hemost. 2000 Apr;6(2):65-8.PMID: 10775023 [PubMed - indexed for MEDLINE]Related articles

    14.

    Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

    Trappenburg MC, van Schilfgaarde M, Marchetti M, Spronk HM, ten Cate H, Leyte A, Terpstra WE, Falanga A.

    Haematologica. 2009 Jul;94(7):911-8. Epub 2009 Jun 8.PMID: 19508974 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT).

    Bernard S, Loffroy R, Sérusclat A, Boussel L, Bonnefoy E, Thévenon C, Rabilloud M, Revel D, Moulin P, Douek P.

    Atherosclerosis. 2009 Apr;203(2):429-35. Epub 2008 Aug 12.PMID: 18804209 [PubMed - indexed for MEDLINE]Related articles

    16.

    Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.

    El-Ghoroury EA, El-Din HG, Abdel-Kader M, Ragab S.

    Blood Coagul Fibrinolysis. 2008 Jan;19(1):7-13.PMID: 18180609 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus.

    Nomura S, Kanazawa S, Fukuhara S.

    J Diabetes Complications. 2003 May-Jun;17(3):153-9.PMID: 12738400 [PubMed - indexed for MEDLINE]Related articles

    18.

    Circulating procoagulant microparticles and soluble GPV in myocardial infarction treated by primary percutaneous transluminal coronary angioplasty. A possible role for GPIIb-IIIa antagonists.

    Morel O, Hugel B, Jesel L, Mallat Z, Lanza F, Douchet MP, Zupan M, Chauvin M, Cazenave JP, Tedgui A, Freyssinet JM, Toti F.

    J Thromb Haemost. 2004 Jul;2(7):1118-26.PMID: 15219195 [PubMed - indexed for MEDLINE]Related articles

    19.

    Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.

    Tan KT, Tayebjee MH, Lim HS, Lip GY.

    Diabet Med. 2005 Dec;22(12):1657-62.PMID: 16401308 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy.

    Choudhury A, Chung I, Blann AD, Lip GY.

    Chest. 2007 Mar;131(3):809-15.PMID: 17356097 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity